Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation? – A statistician's view

This publication has 26 references indexed in Scilit:

• A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children's Cancer Group
  Blood, 2001
• A simple, robust, validated and highly predictive index for the determination of risk‐directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial
  British Journal of Haematology, 1999
• Acute Myeloid Leukemia
  New England Journal of Medicine, 1999
• Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia: results of the United Kingdom Medical Research Council's 10th AML trial
  British Journal of Haematology, 1998
• Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial
  Bone Marrow Transplantation, 1997
• Practical methodology of meta‐analyses (overviews) using updated individual patient data
  Statistics in Medicine, 1995
• Meta-analysis of the literature or of individual patient data: is there a difference?
  The Lancet, 1993
• Vergleich der alleinigen Chemotherapie mit der allogenen Knochenmarktransplantation in erster Vollremission bei Kindern mit akuter myeloischer Leukämie in den Studien AML-BFM-83 und AML-BFM-87 - Matched-Pair-Analyse
  Klinische Padiatrie, 1992
• Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial
  British Journal of Haematology, 1989
• Evaluation of Response-Time Data Involving Transient States: An Illustration Using Heart-Transplant Data
  Journal of the American Statistical Association, 1974